Jennifer H. Anolik, M.D., Ph.D.
See information for Patients. Viewing information for Researchers.
Current Appointments
- Associate Professor - Department of Medicine (SMD)
- Associate Professor - Department of Pathology and Laboratory Medicine (SMD)
| Journal Articles |
|---|
| Showing 45 journal articles currently available. |
| Palanichamy, A.; Barnard, J.; Zheng, B.; Owen, T.; Quach, T.; Wei, C.; Looney, R.J.; Sanz, I.; Anolik, J.H. "Novel populations of human transitional B cells revealed by B cell depletion therapy". Journal of Immunology (2009). |
| Coca, A.; Anolik, J. "Two negative randomized controlled trials in lupus: now what? Faculty of 1000 invited commentary". (2009). |
| Anolik, J.; Looney, R.J.; Lund, F.; Randall, T.; Sanz, I. "Insights into the heterogeneity of human B cells: diversefunctions, roles in autoimmunity, and use as therapeutic targets". Immunologic Research (2009). |
| Walker, AR.; Kleiner, A.; Rich, L.; Conners, C.; Fisher, RI.; Anolik, JH.; Friedberg, JW. "Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma". Cancer Investigations 26 (2008): 431-433. |
| Coca, A.; Anolik, J. "Targeted Biologic Approaches to the Treatment of Systemic Vasculitis". Clinic Reviews in Allergy and Immunology 35 (2008): 79. |
| Anolik JH; Ravikumar R; Barnard J; Owen T; Almudevar A; Milner EC; Miller CH; Dutcher PO; Hadley JA; Sanz I. "Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks." Journal of immunology (Baltimore, Md. : 1950). 2008; 180(2):688-92. |
| Coca A; Anolik JH. "Targeted biologic approaches to the treatment of systemic vasculitis." Clinical reviews in allergy & immunology. 2008; 35(1-2):79-87. |
| Mehta LR; Samuelsson MK; Kleiner AK; Goodman AD; Anolik JH; Looney RJ; Schwid SR. "Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome." Multiple sclerosis (Houndmills, Basingstoke, England). 2008; 14(3):425-7. Epub 2008 Jan 21. |
| Sanz I; Wei C; Lee FE; Anolik J. "Phenotypic and functional heterogeneity of human memory B cells." Seminars in immunology. 2008; 20(1):67-82. Epub 2008 Feb 06. |
| Ravikumar, R.; Anolik, JH.; Looney, RH. "Vaccine responses in patients with rheumatoid arthritis". Current Rheumatoloy Reports 9 (2007): 407-415. |
| Anolik, JH. "B cell biology and dysfunction in SLE". Bulliten of the New York University Hospital of Joint Disease 65 (2007): 182-186. |
| Anolik JH; Friedberg JW; Zheng B; Barnard J; Owen T; Cushing E; Kelly J; Milner EC; Fisher RI; Sanz I. "B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny." Clinical immunology (Orlando, Fla.). 2007; 122(2):139-45. Epub 2006 Sep 27. |
| Sanz I; Anolik JH; Looney RJ. "B cell depletion therapy in autoimmune diseases." Frontiers in bioscience : a journal and virtual library. 2007; 12():2546-67. Epub 2007 Jan 01. |
| Wei C; Anolik J; Cappione A; Zheng B; Pugh-Bernard A; Brooks J; Lee EH; Milner EC; Sanz I. "A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus." Journal of immunology (Baltimore, Md. : 1950). 2007; 178(10):6624-33. |
| Anolik JH; Barnard J; Owen T; Zheng B; Kemshetti S; Looney RJ; Sanz I. "Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy." Arthritis and rheumatism. 2007; 56(9):3044-56. |
| Sabahi, R.; Anolik, JH. "B cell targeted therapy for systemic lupus eryethematosus". Drugs 66 (2006): 1. |
| Looney RJ; Anolik J; Sanz I. "New therapies for systemic lupus erythematosus: cellular targets." Rheumatic diseases clinics of North America. 2006; 32(1):201-15, xi. |
| Anolik, JH.; Aringer, M. "New treatments for SLE: Cell -depleting and anti-cytokine therapies". Best Practices and Research Clinical Rheumatology 19 (2005): 859. |
| Milner EC; Anolik J; Cappione A; Sanz I. "Human innate B cells: a link between host defense and autoimmunity?" Springer seminars in immunopathology. 2005; 26(4):433-52. Epub 2005 Jan 05. |
| Sanz I; Anolik J. "Reconstitution of the adult B cell repertoire after treatment with rituximab." Arthritis research & therapy. 2005; 7(5):175-6. Epub 2005 Jul 22. |
| Cappione A; Anolik JH; Pugh-Bernard A; Barnard J; Dutcher P; Silverman G; Sanz I. "Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus." The Journal of clinical investigation. 2005; 115(11):3205-16. Epub 2005 Oct 06. |
| Cappione AJ; Pugh-Bernard AE; Anolik JH; Sanz I. "Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes." Journal of immunology (Baltimore, Md. : 1950). 2004; 172(7):4298-307. |
| Looney RJ; Anolik J; Sanz I. "B cells as therapeutic targets for rheumatic diseases." Current opinion in rheumatology. 2004; 16(3):180-5. |
| Looney RJ; Anolik J; Sanz I. "B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells." Lupus. 2004; 13(5):381-90. |
| Anolik J; Sanz I. "B cells in human and murine systemic lupus erythematosus." Current opinion in rheumatology. 2004; 16(5):505-12. |
| Looney RJ; Anolik JH; Campbell D; Felgar RE; Young F; Arend LJ; Sloand JA; Rosenblatt J; Sanz I. "B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab." Arthritis and rheumatism. 2004; 50(8):2580-9. |
| Anolik JH; Barnard J; Cappione A; Pugh-Bernard AE; Felgar RE; Looney RJ; Sanz I. "Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus." Arthritis and rheumatism. 2004; 50(11):3580-90. |
| Anolik JH; Campbell D; Felgar RE; Young F; Sanz I; Rosenblatt J; Looney RJ. "The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus." Arthritis and rheumatism. 2003; 48(2):455-9. |
| Anolik J; Looney RJ; Bottaro A; Sanz I; Young F. "Down-regulation of CD20 on B cells upon CD40 activation." European journal of immunology. 2003; 33(9):2398-409. |
| Anolik J; Sanz I; Looney RJ. "B cell depletion therapy in systemic lupus erythematosus." Current rheumatology reports. 2003; 5(5):350-6. |
| Anolik JH; Wildy K; Cohn SE; Marquardt JD; Totterman S; Zwillich SH. "Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritis." The Journal of rheumatology. 2001; 28(1):217-20. |
| Anolik JH; Blumberg N; Snider J; Francis CW. "Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a (Br(b))." Transfusion. 2001; 41(5):633-6. |
| Anolik, JH.; Ritchlin, C. "A 40 year old woman with destructive arthritis and severe interstitial lung disease". AML Interactions (2000). |
| Anolik JH; Di Giovanna JJ; Gaspari AA. "Effect of isotretinoin therapy on natural killer cell activity in patients with xeroderma pigmentosum." The British journal of dermatology. 1998; 138(2):236-41. |
| Sathya G; Li W; Klinge CM; Anolik JH; Hilf R; Bambara RA. "Effects of multiple estrogen responsive elements, their spacing, and location on estrogen response of reporter genes." Molecular endocrinology (Baltimore, Md.). 1997; 11(13):1994-2003. |
| Anolik JH; Klinge CM; Brolly CL; Bambara RA; Hilf R. "Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors." The Journal of steroid biochemistry and molecular biology. 1996; 59(5-6):413-29. |
| Anolik,J. H.; Klinge,C. M.; Hilf,R.; Bambara,R. A. "Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand". Biochemistry (John Wiley & Sons) 34 (1995): 2511,2520. |
| Anolik, JA. "Estrogen receptor interaction with estrogen response element (ERE) DNA: Role of ligand, ERE spacing, flanking sequences". (1994). |
| Anolik JH; Klinge CM; Bambara RA; Hilf R. "Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA." The Journal of steroid biochemistry and molecular biology. 1993; 46(6):713-30. |
| Shinnar, AE.; Anolik, JH.; Johnson, DA.; Lobl, TJ. "Physical and conformational properties of a synthetic leader peptide from bovine serum albumin". Proceedings of the Eleventh American Peptide Symposium (1990). |
| Palanichamy, A.; Barnard, J.; Zheng, B.; Wei, C.; Owen, T.; Cushing, E.; Campbell, D.; Kemshetti, S.; Looney, R.J.; Sanz, I.; Anolik, J.H. "Expansion of transitional B cells in human SLE". In Preperation. |
| Bekar, K.; Owen, T.; Dunn, R.; Kehry, M.; Anolik, J.H. "Treatment with anti-CD20 prevents and reverses murine lupus". In preparation. |
| Sabahi, R.; Owen, T.; Barnard, J.; Cushing, E.; Looney, R.J.; Sanz, I.; Anolik, J.H. "Immunologic effects of BAFF antagonism in the treatment of human SLE". In preparation. |
| Barnard, J.; Palanichamy, A.; Bauer, J.W.; Koeuth, T.; Baechler, E.C.; Anolik, J.H. "Interferon activation in human SLE bone marrow inhibits B cell lymphopoeisis". In preparation. |
| Wang, R.; Owen, T.; Bekar, K.; Anolik, J. "TLR9 stimulation adversely impacts B cell depletion and reconstitution in the mouse". In preparation. |
